The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis
- 1 February 1991
- journal article
- case report
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 21 (S1) , 52-54
- https://doi.org/10.1111/j.1445-5994.1991.tb03003.x
Abstract
We report two cases of heparin induced thrombocytopenia (HIT), in patients who required anticoagulation for extracorporeal procedures (haemodialysis and cardiopulmonary bypass) one associated with recurrent thrombosis of the artificial circuits. Resolution of thrombocytopenia and successful anticoagulation were achieved using a low molecular weight heparinoid (LMWH) Org 10172. Anticoagulation was monitored using estimations of plasma anti-factor Xa activity. These cases demonstrate that LMWH provides safe and effective anticoagulation in patients in whom unfractionated heparin has caused HIT.Keywords
This publication has 8 references indexed in Scilit:
- An International Standard for Low Molecular Weight HeparinThrombosis and Haemostasis, 1988
- Protamine reversal of anticoagulation achieved with a low molecular weight heparin. The effects on eicosanoids, clotting and complement factorsThrombosis Research, 1987
- Management of Patients with Heparin-Associated Thrombocytopenia and Thrombosis Requiring Cardiac SurgeryThe Annals of Thoracic Surgery, 1987
- Heparin‐induced Thrombocytopenia: Effect of Heparin Platelet Antibody on PlateletsBritish Journal of Haematology, 1981
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Activated Coagulation Time of Whole BloodJAMA, 1966